Graphique 1 - Faculté de Médecine et de Pharmacie de Fès
Graphique 1 - Faculté de Médecine et de Pharmacie de Fès
Graphique 1 - Faculté de Médecine et de Pharmacie de Fès
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
14. Maciejewski J, Selleri C, An<strong>de</strong>rson S, Young NS. Fas antigen expression on CD34+<br />
human marrow cells is induced by interferon gamma and tumor necrosis factor<br />
alpha and potentiates cytokine-mediated hematopoi<strong>et</strong>ic suppression in vitro. Blood<br />
1995;85:3183–90.<br />
15. Selleri C, Sato T, An<strong>de</strong>rson S, Young NS, Maciejewski JP. Interferon-gamma and<br />
tumor necrosis factor-alpha suppress both early and late stages of hematopoiesis<br />
and induce programmed cell <strong>de</strong>ath. J Cell Physiol 1995;165:538-46.<br />
16. Beyne-Rauzy O, Pra<strong>de</strong>-Hou<strong>de</strong>llier N, Demur C, <strong>et</strong> al. Tumor necrosis factor-alpha<br />
inhibits hTERT gene expression in human myeloid normal and leukemic cells.<br />
Blood 2005;106:3200–5 [Epub, 2005 Jul 14].<br />
17. De Maria R, Testa U, Luch<strong>et</strong>ti L, <strong>et</strong> al. Apoptotic role of Fas/Fas ligand system in<br />
the regulation of erythropoiesis. Nature 1999;93:796–803.<br />
18. Pra<strong>de</strong>-Hou<strong>de</strong>llier N, Freb<strong>et</strong> E, Demur C, <strong>et</strong> al. Human telomerase is regulated by<br />
erythropoi<strong>et</strong>in and transforming growth factor-b<strong>et</strong>a in human erythroid progenitor<br />
cells. Leukemia 2007;21:2304–10 [Epub, 2007Aug 23].<br />
19. Johnson CS, Cook CA, Furmanski P. In vivo suppression of erythropoiesis by tumor<br />
necrosis factor-alpha (TNF-alpha): reversal with exogenous erythropoi<strong>et</strong>in (EPO).<br />
Exp Hematol 1990;18:109–13.<br />
20. Jelkmann W. Proinflammatory cytokines lowering erythropoi<strong>et</strong>in production. J<br />
Interferon Cytokine Res 1998;18:555–9.<br />
21. Boyd HK, Lappin TR, Bell AL. Evi<strong>de</strong>nce for impaired erythropoi<strong>et</strong>in response to<br />
anaemia in rheumatoid disease. Br J Rheumatol 1991;30:255–9.<br />
22. Sch<strong>et</strong>t G, Firbas U, Fure<strong>de</strong>r W, <strong>et</strong> al. Decreased serum erythropoi<strong>et</strong>in and its<br />
relation to anti-erythropoi<strong>et</strong>in antibodies in anaemia of systemic lupus<br />
erythematosus. Rheumatology (Oxford) 2001;40: 424–431.<br />
23. Minoo P, Za<strong>de</strong>h MM, Rottapel R, Lebrun JJ, Ali S. A novel SHP-1/Grb2-<strong>de</strong>pen<strong>de</strong>nt<br />
mechanism of negative regulation of cytokine-receptor signaling: contribution of<br />
SHP-1 C-terminal tyrosines in cytokine signaling. Blood 2004;103:1398–407<br />
[Epub, 2003Oct 9].<br />
24. Roy CN,Mak HH, Akpan I, Losyev G, Zurakowski D, Andrews NC. Hepcidin<br />
antimicrobial pepti<strong>de</strong> transgenic mice exhibit features of the anemia of<br />
inflammation. Blood 2007;109:4038–44 [Epub 2007 Jan 11].<br />
25. Nem<strong>et</strong>h E, Tuttle MS, Powelson J, <strong>et</strong> al. Hepcidin regulates cellular iron efflux by<br />
binding to ferroportin and inducing its internalization. Science 2004;306:2090–3<br />
[Epub 2004Oct 28].<br />
26. Nicolas G, Chauv<strong>et</strong> C,Viatte L, <strong>et</strong> al. The gene encoding the iron regulatory pepti<strong>de</strong><br />
hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest<br />
2002;110:1037–44.<br />
195